Dechra profits from competitor supply woe
Date added:
28/04/2015
CHESHIRE pet pharmaceuticals group Dechra has seen its revenue increase significantly in its third quarter. In a statement covering the period from the start of the year to date, the group said trading has been strong but points out it has benefited from the phasing of pre-Easter ordering in Europe and competitor stock shortages in the US. Group revenue in this quarter (the firm’s third) increased by 14.3% at constant exchange rate (CER). For the nine months ended 31 March 2015, revenue growth was 12.3% at CER (6.6% at AER...
Back to all news